nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—ABCB1—kidney cancer	0.0972	1	CbGaD
Glyburide—SLCO2B1—Erlotinib—kidney cancer	0.0373	0.0609	CbGbCtD
Glyburide—ABCB11—Paclitaxel—kidney cancer	0.0295	0.0482	CbGbCtD
Glyburide—ABCC3—Vincristine—kidney cancer	0.0295	0.048	CbGbCtD
Glyburide—ABCC1—Dactinomycin—kidney cancer	0.0294	0.0479	CbGbCtD
Glyburide—ABCB11—Vinblastine—kidney cancer	0.0259	0.0422	CbGbCtD
Glyburide—ABCB11—Vincristine—kidney cancer	0.0255	0.0415	CbGbCtD
Glyburide—ABCG2—Pazopanib—kidney cancer	0.0215	0.035	CbGbCtD
Glyburide—ABCC1—Paclitaxel—kidney cancer	0.021	0.0342	CbGbCtD
Glyburide—ABCG2—Dactinomycin—kidney cancer	0.0197	0.0321	CbGbCtD
Glyburide—ABCC3—Doxorubicin—kidney cancer	0.0184	0.03	CbGbCtD
Glyburide—ABCC1—Vinblastine—kidney cancer	0.0184	0.03	CbGbCtD
Glyburide—ABCC1—Vincristine—kidney cancer	0.0181	0.0295	CbGbCtD
Glyburide—KCNJ1—collecting duct of renal tubule—kidney cancer	0.0181	0.253	CbGeAlD
Glyburide—ABCB11—Doxorubicin—kidney cancer	0.0159	0.026	CbGbCtD
Glyburide—ABCC2—Paclitaxel—kidney cancer	0.0155	0.0253	CbGbCtD
Glyburide—ABCG2—Erlotinib—kidney cancer	0.0153	0.025	CbGbCtD
Glyburide—ABCB1—Temsirolimus—kidney cancer	0.0148	0.0241	CbGbCtD
Glyburide—ABCG2—Paclitaxel—kidney cancer	0.014	0.0229	CbGbCtD
Glyburide—ABCC2—Sorafenib—kidney cancer	0.0138	0.0225	CbGbCtD
Glyburide—ABCC2—Vinblastine—kidney cancer	0.0136	0.0222	CbGbCtD
Glyburide—ABCC2—Vincristine—kidney cancer	0.0134	0.0218	CbGbCtD
Glyburide—CYP3A4—Everolimus—kidney cancer	0.0131	0.0213	CbGbCtD
Glyburide—ABCG2—Sorafenib—kidney cancer	0.0125	0.0203	CbGbCtD
Glyburide—ABCG2—Vincristine—kidney cancer	0.0121	0.0197	CbGbCtD
Glyburide—ABCC1—Doxorubicin—kidney cancer	0.0113	0.0184	CbGbCtD
Glyburide—ABCC2—Sunitinib—kidney cancer	0.0112	0.0182	CbGbCtD
Glyburide—ALB—Erlotinib—kidney cancer	0.0106	0.0172	CbGbCtD
Glyburide—ABCG2—Sunitinib—kidney cancer	0.0101	0.0165	CbGbCtD
Glyburide—CYP3A4—Temsirolimus—kidney cancer	0.00884	0.0144	CbGbCtD
Glyburide—ABCC2—Doxorubicin—kidney cancer	0.00837	0.0136	CbGbCtD
Glyburide—CYP2C9—Capecitabine—kidney cancer	0.00833	0.0136	CbGbCtD
Glyburide—KCNJ1—nephron—kidney cancer	0.00804	0.113	CbGeAlD
Glyburide—ABCB1—Pazopanib—kidney cancer	0.00775	0.0126	CbGbCtD
Glyburide—ABCG2—Doxorubicin—kidney cancer	0.00757	0.0123	CbGbCtD
Glyburide—ABCB1—Dactinomycin—kidney cancer	0.00709	0.0116	CbGbCtD
Glyburide—ABCB1—Gemcitabine—kidney cancer	0.0056	0.00914	CbGbCtD
Glyburide—CYP2C19—Sorafenib—kidney cancer	0.00557	0.00909	CbGbCtD
Glyburide—ABCB1—Erlotinib—kidney cancer	0.00553	0.00902	CbGbCtD
Glyburide—CYP2C9—Paclitaxel—kidney cancer	0.00522	0.00851	CbGbCtD
Glyburide—ABCB1—Paclitaxel—kidney cancer	0.00506	0.00826	CbGbCtD
Glyburide—CYP3A4—Pazopanib—kidney cancer	0.00464	0.00757	CbGbCtD
Glyburide—CYP2C9—Sorafenib—kidney cancer	0.00463	0.00756	CbGbCtD
Glyburide—ABCB1—Sorafenib—kidney cancer	0.0045	0.00733	CbGbCtD
Glyburide—ABCB1—Vinblastine—kidney cancer	0.00444	0.00724	CbGbCtD
Glyburide—ABCB1—Vincristine—kidney cancer	0.00437	0.00712	CbGbCtD
Glyburide—ABCB1—Sunitinib—kidney cancer	0.00364	0.00594	CbGbCtD
Glyburide—CYP3A4—Erlotinib—kidney cancer	0.00331	0.0054	CbGbCtD
Glyburide—CYP3A4—Paclitaxel—kidney cancer	0.00303	0.00495	CbGbCtD
Glyburide—ABCB1—Doxorubicin—kidney cancer	0.00273	0.00445	CbGbCtD
Glyburide—CYP3A4—Sorafenib—kidney cancer	0.00269	0.00439	CbGbCtD
Glyburide—CYP3A4—Vinblastine—kidney cancer	0.00266	0.00434	CbGbCtD
Glyburide—KCNJ5—cardiac atrium—kidney cancer	0.00262	0.0367	CbGeAlD
Glyburide—CYP3A4—Vincristine—kidney cancer	0.00262	0.00426	CbGbCtD
Glyburide—CYP3A4—Sunitinib—kidney cancer	0.00218	0.00356	CbGbCtD
Glyburide—CYP2C19—urine—kidney cancer	0.00208	0.0291	CbGeAlD
Glyburide—KCNJ1—nephron tubule—kidney cancer	0.00174	0.0243	CbGeAlD
Glyburide—CYP3A4—Doxorubicin—kidney cancer	0.00164	0.00267	CbGbCtD
Glyburide—CPT1A—renal system—kidney cancer	0.00161	0.0226	CbGeAlD
Glyburide—CYP2C9—urine—kidney cancer	0.00161	0.0226	CbGeAlD
Glyburide—KCNJ1—renal system—kidney cancer	0.00158	0.0221	CbGeAlD
Glyburide—CPT1A—kidney—kidney cancer	0.00156	0.0218	CbGeAlD
Glyburide—KCNJ1—kidney—kidney cancer	0.00153	0.0214	CbGeAlD
Glyburide—ABCA1—renal system—kidney cancer	0.0015	0.021	CbGeAlD
Glyburide—KCNJ1—cortex of kidney—kidney cancer	0.00149	0.0208	CbGeAlD
Glyburide—ABCA1—kidney—kidney cancer	0.00145	0.0203	CbGeAlD
Glyburide—CPT1A—gonad—kidney cancer	0.00145	0.0202	CbGeAlD
Glyburide—CFTR—renal system—kidney cancer	0.00142	0.0199	CbGeAlD
Glyburide—CFTR—kidney—kidney cancer	0.00137	0.0192	CbGeAlD
Glyburide—CYP3A4—urine—kidney cancer	0.00123	0.0172	CbGeAlD
Glyburide—SLC22A6—nephron tubule—kidney cancer	0.00111	0.0156	CbGeAlD
Glyburide—SLC22A7—renal system—kidney cancer	0.00105	0.0147	CbGeAlD
Glyburide—SLC22A7—kidney—kidney cancer	0.00101	0.0142	CbGeAlD
Glyburide—SLC22A7—cortex of kidney—kidney cancer	0.000988	0.0138	CbGeAlD
Glyburide—Sulpiride—CA9—kidney cancer	0.000958	0.224	CrCbGaD
Glyburide—SLC22A6—cortex of kidney—kidney cancer	0.000954	0.0134	CbGeAlD
Glyburide—SLC15A1—nephron tubule—kidney cancer	0.000928	0.013	CbGeAlD
Glyburide—ABCC8—renal system—kidney cancer	0.000882	0.0124	CbGeAlD
Glyburide—Sulpiride—CA2—kidney cancer	0.000862	0.201	CrCbGaD
Glyburide—ABCC8—kidney—kidney cancer	0.000853	0.0119	CbGeAlD
Glyburide—SLC15A1—renal system—kidney cancer	0.000843	0.0118	CbGeAlD
Glyburide—SLC15A1—kidney—kidney cancer	0.000815	0.0114	CbGeAlD
Glyburide—ABCC3—renal system—kidney cancer	0.000741	0.0104	CbGeAlD
Glyburide—Gliclazide—VEGFA—kidney cancer	0.000722	0.169	CrCbGaD
Glyburide—ABCC3—kidney—kidney cancer	0.000716	0.01	CbGeAlD
Glyburide—SLCO2B1—renal system—kidney cancer	0.00069	0.00967	CbGeAlD
Glyburide—SLCO2B1—kidney—kidney cancer	0.000667	0.00935	CbGeAlD
Glyburide—ABCC2—nephron tubule—kidney cancer	0.000651	0.00912	CbGeAlD
Glyburide—SLCO1A2—renal system—kidney cancer	0.000635	0.0089	CbGeAlD
Glyburide—SLCO1A2—kidney—kidney cancer	0.000614	0.0086	CbGeAlD
Glyburide—ABCC2—renal system—kidney cancer	0.000592	0.00829	CbGeAlD
Glyburide—Sulpiride—BCHE—kidney cancer	0.000587	0.137	CrCbGaD
Glyburide—SLC15A2—nephron tubule—kidney cancer	0.00058	0.00812	CbGeAlD
Glyburide—ABCC2—kidney—kidney cancer	0.000572	0.00801	CbGeAlD
Glyburide—ABCC2—cortex of kidney—kidney cancer	0.000557	0.0078	CbGeAlD
Glyburide—SLC15A2—renal system—kidney cancer	0.000527	0.00738	CbGeAlD
Glyburide—SLC15A2—kidney—kidney cancer	0.00051	0.00714	CbGeAlD
Glyburide—SLC15A2—cortex of kidney—kidney cancer	0.000496	0.00695	CbGeAlD
Glyburide—ABCC1—cortex of kidney—kidney cancer	0.000491	0.00687	CbGeAlD
Glyburide—ABCG2—nephron tubule—kidney cancer	0.000475	0.00665	CbGeAlD
Glyburide—ABCC1—cardiac atrium—kidney cancer	0.000467	0.00654	CbGeAlD
Glyburide—Zafirlukast—PTGS1—kidney cancer	0.000443	0.103	CrCbGaD
Glyburide—CYP3A4—renal system—kidney cancer	0.000301	0.00421	CbGeAlD
Glyburide—Chlorpropamide—PTGS1—kidney cancer	0.000297	0.0692	CrCbGaD
Glyburide—CYP3A4—kidney—kidney cancer	0.000291	0.00407	CbGeAlD
Glyburide—Bezafibrate—CYP1A1—kidney cancer	0.000274	0.0638	CrCbGaD
Glyburide—ABCB1—nephron tubule—kidney cancer	0.000234	0.00328	CbGeAlD
Glyburide—ABCB1—renal system—kidney cancer	0.000213	0.00298	CbGeAlD
Glyburide—ABCB1—kidney—kidney cancer	0.000206	0.00288	CbGeAlD
Glyburide—ABCB1—cortex of kidney—kidney cancer	0.0002	0.00281	CbGeAlD
Glyburide—ABCB1—gonad—kidney cancer	0.000191	0.00267	CbGeAlD
Glyburide—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000174	0.00129	CcSEcCtD
Glyburide—Anaemia—Gemcitabine—kidney cancer	0.000174	0.00128	CcSEcCtD
Glyburide—Decreased appetite—Sorafenib—kidney cancer	0.000173	0.00128	CcSEcCtD
Glyburide—Anorexia—Dactinomycin—kidney cancer	0.000173	0.00127	CcSEcCtD
Glyburide—Nausea—Pazopanib—kidney cancer	0.000172	0.00127	CcSEcCtD
Glyburide—Paraesthesia—Sunitinib—kidney cancer	0.000172	0.00127	CcSEcCtD
Glyburide—Convulsion—Vincristine—kidney cancer	0.000172	0.00127	CcSEcCtD
Glyburide—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000172	0.00127	CcSEcCtD
Glyburide—Dyspnoea—Sunitinib—kidney cancer	0.000171	0.00126	CcSEcCtD
Glyburide—Hypersensitivity—Vinblastine—kidney cancer	0.000169	0.00125	CcSEcCtD
Glyburide—Photosensitivity reaction—Capecitabine—kidney cancer	0.000169	0.00125	CcSEcCtD
Glyburide—Eye disorder—Paclitaxel—kidney cancer	0.000169	0.00125	CcSEcCtD
Glyburide—Myalgia—Vincristine—kidney cancer	0.000169	0.00125	CcSEcCtD
Glyburide—Hypersensitivity—Everolimus—kidney cancer	0.000169	0.00125	CcSEcCtD
Glyburide—Dyspepsia—Sunitinib—kidney cancer	0.000168	0.00124	CcSEcCtD
Glyburide—Leukopenia—Gemcitabine—kidney cancer	0.000168	0.00124	CcSEcCtD
Glyburide—Decreased appetite—Sunitinib—kidney cancer	0.000166	0.00123	CcSEcCtD
Glyburide—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000165	0.00122	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000165	0.00122	CcSEcCtD
Glyburide—Asthenia—Vinblastine—kidney cancer	0.000165	0.00122	CcSEcCtD
Glyburide—Asthenia—Everolimus—kidney cancer	0.000164	0.00121	CcSEcCtD
Glyburide—Gastrointestinal pain—Sorafenib—kidney cancer	0.000163	0.0012	CcSEcCtD
Glyburide—Pruritus—Everolimus—kidney cancer	0.000162	0.0012	CcSEcCtD
Glyburide—Oedema—Vincristine—kidney cancer	0.000162	0.00119	CcSEcCtD
Glyburide—Jaundice—Capecitabine—kidney cancer	0.000161	0.00119	CcSEcCtD
Glyburide—Myalgia—Gemcitabine—kidney cancer	0.00016	0.00118	CcSEcCtD
Glyburide—Arthralgia—Gemcitabine—kidney cancer	0.00016	0.00118	CcSEcCtD
Glyburide—Alopecia—Paclitaxel—kidney cancer	0.00016	0.00118	CcSEcCtD
Glyburide—Nervous system disorder—Vincristine—kidney cancer	0.000159	0.00117	CcSEcCtD
Glyburide—Asthenia—Erlotinib—kidney cancer	0.000159	0.00117	CcSEcCtD
Glyburide—Thrombocytopenia—Vincristine—kidney cancer	0.000158	0.00117	CcSEcCtD
Glyburide—Hepatic function abnormal—Doxorubicin—kidney cancer	0.000158	0.00117	CcSEcCtD
Glyburide—Urticaria—Sorafenib—kidney cancer	0.000158	0.00117	CcSEcCtD
Glyburide—Malnutrition—Paclitaxel—kidney cancer	0.000158	0.00116	CcSEcCtD
Glyburide—Erythema—Paclitaxel—kidney cancer	0.000158	0.00116	CcSEcCtD
Glyburide—Decreased appetite—Dactinomycin—kidney cancer	0.000157	0.00116	CcSEcCtD
Glyburide—Diarrhoea—Vinblastine—kidney cancer	0.000157	0.00116	CcSEcCtD
Glyburide—Abdominal pain—Sorafenib—kidney cancer	0.000157	0.00116	CcSEcCtD
Glyburide—Diarrhoea—Everolimus—kidney cancer	0.000157	0.00116	CcSEcCtD
Glyburide—Gastrointestinal pain—Sunitinib—kidney cancer	0.000156	0.00115	CcSEcCtD
Glyburide—Hyperhidrosis—Vincristine—kidney cancer	0.000156	0.00115	CcSEcCtD
Glyburide—Pruritus—Erlotinib—kidney cancer	0.000156	0.00115	CcSEcCtD
Glyburide—Vascular purpura—Doxorubicin—kidney cancer	0.000155	0.00114	CcSEcCtD
Glyburide—Agranulocytosis—Capecitabine—kidney cancer	0.000154	0.00114	CcSEcCtD
Glyburide—Anorexia—Vincristine—kidney cancer	0.000154	0.00114	CcSEcCtD
Glyburide—Hepatic failure—Doxorubicin—kidney cancer	0.000154	0.00114	CcSEcCtD
Glyburide—Oedema—Gemcitabine—kidney cancer	0.000154	0.00113	CcSEcCtD
Glyburide—Abdominal pain—Sunitinib—kidney cancer	0.000151	0.00112	CcSEcCtD
Glyburide—Diarrhoea—Erlotinib—kidney cancer	0.000151	0.00112	CcSEcCtD
Glyburide—Hypotension—Vincristine—kidney cancer	0.000151	0.00112	CcSEcCtD
Glyburide—Nervous system disorder—Gemcitabine—kidney cancer	0.000151	0.00111	CcSEcCtD
Glyburide—Thrombocytopenia—Gemcitabine—kidney cancer	0.00015	0.00111	CcSEcCtD
Glyburide—Renal failure acute—Doxorubicin—kidney cancer	0.00015	0.00111	CcSEcCtD
Glyburide—Feeling abnormal—Dactinomycin—kidney cancer	0.000149	0.0011	CcSEcCtD
Glyburide—Hepatitis—Capecitabine—kidney cancer	0.000148	0.0011	CcSEcCtD
Glyburide—Vision blurred—Paclitaxel—kidney cancer	0.000148	0.0011	CcSEcCtD
Glyburide—Hyperhidrosis—Gemcitabine—kidney cancer	0.000148	0.00109	CcSEcCtD
Glyburide—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000148	0.00109	CcSEcCtD
Glyburide—Tremor—Paclitaxel—kidney cancer	0.000148	0.00109	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000147	0.00109	CcSEcCtD
Glyburide—Hypersensitivity—Sorafenib—kidney cancer	0.000147	0.00108	CcSEcCtD
Glyburide—Anorexia—Gemcitabine—kidney cancer	0.000146	0.00108	CcSEcCtD
Glyburide—Vomiting—Vinblastine—kidney cancer	0.000146	0.00108	CcSEcCtD
Glyburide—Vomiting—Everolimus—kidney cancer	0.000146	0.00107	CcSEcCtD
Glyburide—Anaemia—Paclitaxel—kidney cancer	0.000146	0.00107	CcSEcCtD
Glyburide—Renal impairment—Doxorubicin—kidney cancer	0.000145	0.00107	CcSEcCtD
Glyburide—Paraesthesia—Vincristine—kidney cancer	0.000145	0.00107	CcSEcCtD
Glyburide—Dermatitis bullous—Doxorubicin—kidney cancer	0.000145	0.00107	CcSEcCtD
Glyburide—Rash—Everolimus—kidney cancer	0.000144	0.00107	CcSEcCtD
Glyburide—Dermatitis—Everolimus—kidney cancer	0.000144	0.00106	CcSEcCtD
Glyburide—Chlorpropamide—ABCB1—kidney cancer	0.000144	0.0336	CrCbGaD
Glyburide—Headache—Vinblastine—kidney cancer	0.000144	0.00106	CcSEcCtD
Glyburide—Angioedema—Paclitaxel—kidney cancer	0.000144	0.00106	CcSEcCtD
Glyburide—Purpura—Doxorubicin—kidney cancer	0.000144	0.00106	CcSEcCtD
Glyburide—Headache—Everolimus—kidney cancer	0.000144	0.00106	CcSEcCtD
Glyburide—Hypotension—Gemcitabine—kidney cancer	0.000143	0.00106	CcSEcCtD
Glyburide—Abdominal pain—Dactinomycin—kidney cancer	0.000143	0.00106	CcSEcCtD
Glyburide—Visual impairment—Capecitabine—kidney cancer	0.000143	0.00106	CcSEcCtD
Glyburide—Asthenia—Sorafenib—kidney cancer	0.000143	0.00105	CcSEcCtD
Glyburide—Hypoglycaemia—Doxorubicin—kidney cancer	0.000142	0.00105	CcSEcCtD
Glyburide—Leukopenia—Paclitaxel—kidney cancer	0.000141	0.00104	CcSEcCtD
Glyburide—Hypersensitivity—Sunitinib—kidney cancer	0.000141	0.00104	CcSEcCtD
Glyburide—Decreased appetite—Vincristine—kidney cancer	0.000141	0.00104	CcSEcCtD
Glyburide—Pruritus—Sorafenib—kidney cancer	0.000141	0.00104	CcSEcCtD
Glyburide—Vomiting—Erlotinib—kidney cancer	0.000141	0.00104	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00014	0.00103	CcSEcCtD
Glyburide—Gastrointestinal disorder—Vincristine—kidney cancer	0.00014	0.00103	CcSEcCtD
Glyburide—Rash—Erlotinib—kidney cancer	0.000139	0.00103	CcSEcCtD
Glyburide—Dermatitis—Erlotinib—kidney cancer	0.000139	0.00103	CcSEcCtD
Glyburide—Hyponatraemia—Doxorubicin—kidney cancer	0.000139	0.00102	CcSEcCtD
Glyburide—Eye disorder—Capecitabine—kidney cancer	0.000139	0.00102	CcSEcCtD
Glyburide—Headache—Erlotinib—kidney cancer	0.000138	0.00102	CcSEcCtD
Glyburide—Diplopia—Doxorubicin—kidney cancer	0.000138	0.00102	CcSEcCtD
Glyburide—Paraesthesia—Gemcitabine—kidney cancer	0.000138	0.00102	CcSEcCtD
Glyburide—Asthenia—Sunitinib—kidney cancer	0.000137	0.00101	CcSEcCtD
Glyburide—Dyspnoea—Gemcitabine—kidney cancer	0.000137	0.00101	CcSEcCtD
Glyburide—Nausea—Vinblastine—kidney cancer	0.000137	0.00101	CcSEcCtD
Glyburide—Convulsion—Paclitaxel—kidney cancer	0.000136	0.00101	CcSEcCtD
Glyburide—Nausea—Everolimus—kidney cancer	0.000136	0.001	CcSEcCtD
Glyburide—Diarrhoea—Sorafenib—kidney cancer	0.000136	0.001	CcSEcCtD
Glyburide—Pruritus—Sunitinib—kidney cancer	0.000135	0.000999	CcSEcCtD
Glyburide—Arthralgia—Paclitaxel—kidney cancer	0.000134	0.000989	CcSEcCtD
Glyburide—Myalgia—Paclitaxel—kidney cancer	0.000134	0.000989	CcSEcCtD
Glyburide—Decreased appetite—Gemcitabine—kidney cancer	0.000133	0.000985	CcSEcCtD
Glyburide—Hypersensitivity—Dactinomycin—kidney cancer	0.000133	0.000985	CcSEcCtD
Glyburide—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000133	0.000978	CcSEcCtD
Glyburide—Gastrointestinal pain—Vincristine—kidney cancer	0.000132	0.000976	CcSEcCtD
Glyburide—Nausea—Erlotinib—kidney cancer	0.000131	0.000969	CcSEcCtD
Glyburide—Alopecia—Capecitabine—kidney cancer	0.000131	0.000968	CcSEcCtD
Glyburide—Diarrhoea—Sunitinib—kidney cancer	0.000131	0.000966	CcSEcCtD
Glyburide—Asthenia—Dactinomycin—kidney cancer	0.00013	0.000959	CcSEcCtD
Glyburide—Confusional state—Paclitaxel—kidney cancer	0.00013	0.000956	CcSEcCtD
Glyburide—Erythema—Capecitabine—kidney cancer	0.000129	0.000954	CcSEcCtD
Glyburide—Malnutrition—Capecitabine—kidney cancer	0.000129	0.000954	CcSEcCtD
Glyburide—Oedema—Paclitaxel—kidney cancer	0.000129	0.000948	CcSEcCtD
Glyburide—Abdominal pain—Vincristine—kidney cancer	0.000128	0.000944	CcSEcCtD
Glyburide—Feeling abnormal—Gemcitabine—kidney cancer	0.000127	0.000933	CcSEcCtD
Glyburide—Shock—Paclitaxel—kidney cancer	0.000126	0.000933	CcSEcCtD
Glyburide—Vomiting—Sorafenib—kidney cancer	0.000126	0.000933	CcSEcCtD
Glyburide—Nervous system disorder—Paclitaxel—kidney cancer	0.000126	0.00093	CcSEcCtD
Glyburide—Thrombocytopenia—Paclitaxel—kidney cancer	0.000126	0.000929	CcSEcCtD
Glyburide—Rash—Sorafenib—kidney cancer	0.000125	0.000925	CcSEcCtD
Glyburide—Dermatitis—Sorafenib—kidney cancer	0.000125	0.000924	CcSEcCtD
Glyburide—Headache—Sorafenib—kidney cancer	0.000125	0.000919	CcSEcCtD
Glyburide—Hyperhidrosis—Paclitaxel—kidney cancer	0.000124	0.000917	CcSEcCtD
Glyburide—Diarrhoea—Dactinomycin—kidney cancer	0.000124	0.000914	CcSEcCtD
Glyburide—Anorexia—Paclitaxel—kidney cancer	0.000123	0.000904	CcSEcCtD
Glyburide—Vision blurred—Capecitabine—kidney cancer	0.000122	0.000899	CcSEcCtD
Glyburide—Vomiting—Sunitinib—kidney cancer	0.000122	0.000898	CcSEcCtD
Glyburide—Tremor—Capecitabine—kidney cancer	0.000121	0.000893	CcSEcCtD
Glyburide—Rash—Sunitinib—kidney cancer	0.000121	0.00089	CcSEcCtD
Glyburide—Dermatitis—Sunitinib—kidney cancer	0.000121	0.000889	CcSEcCtD
Glyburide—Abdominal distension—Doxorubicin—kidney cancer	0.00012	0.000888	CcSEcCtD
Glyburide—Hypotension—Paclitaxel—kidney cancer	0.00012	0.000886	CcSEcCtD
Glyburide—Headache—Sunitinib—kidney cancer	0.00012	0.000884	CcSEcCtD
Glyburide—Anaemia—Capecitabine—kidney cancer	0.000119	0.000881	CcSEcCtD
Glyburide—Hypersensitivity—Vincristine—kidney cancer	0.000119	0.00088	CcSEcCtD
Glyburide—Eosinophilia—Doxorubicin—kidney cancer	0.000118	0.000873	CcSEcCtD
Glyburide—Nausea—Sorafenib—kidney cancer	0.000118	0.000871	CcSEcCtD
Glyburide—Pancreatitis—Doxorubicin—kidney cancer	0.000117	0.000865	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000117	0.000864	CcSEcCtD
Glyburide—Asthenia—Vincristine—kidney cancer	0.000116	0.000857	CcSEcCtD
Glyburide—Leukopenia—Capecitabine—kidney cancer	0.000116	0.000854	CcSEcCtD
Glyburide—Paraesthesia—Paclitaxel—kidney cancer	0.000115	0.000852	CcSEcCtD
Glyburide—Vomiting—Dactinomycin—kidney cancer	0.000115	0.00085	CcSEcCtD
Glyburide—Dyspnoea—Paclitaxel—kidney cancer	0.000115	0.000845	CcSEcCtD
Glyburide—Rash—Dactinomycin—kidney cancer	0.000114	0.000843	CcSEcCtD
Glyburide—Nausea—Sunitinib—kidney cancer	0.000114	0.000838	CcSEcCtD
Glyburide—Pancytopenia—Doxorubicin—kidney cancer	0.000114	0.000838	CcSEcCtD
Glyburide—Dyspepsia—Paclitaxel—kidney cancer	0.000113	0.000835	CcSEcCtD
Glyburide—Decreased appetite—Paclitaxel—kidney cancer	0.000112	0.000824	CcSEcCtD
Glyburide—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000111	0.000819	CcSEcCtD
Glyburide—Diarrhoea—Vincristine—kidney cancer	0.000111	0.000817	CcSEcCtD
Glyburide—Asthenia—Gemcitabine—kidney cancer	0.00011	0.000813	CcSEcCtD
Glyburide—Arthralgia—Capecitabine—kidney cancer	0.00011	0.000812	CcSEcCtD
Glyburide—Myalgia—Capecitabine—kidney cancer	0.00011	0.000812	CcSEcCtD
Glyburide—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000109	0.000805	CcSEcCtD
Glyburide—Pruritus—Gemcitabine—kidney cancer	0.000109	0.000801	CcSEcCtD
Glyburide—Nausea—Dactinomycin—kidney cancer	0.000108	0.000794	CcSEcCtD
Glyburide—Confusional state—Capecitabine—kidney cancer	0.000106	0.000785	CcSEcCtD
Glyburide—Feeling abnormal—Paclitaxel—kidney cancer	0.000106	0.000781	CcSEcCtD
Glyburide—Oedema—Capecitabine—kidney cancer	0.000105	0.000778	CcSEcCtD
Glyburide—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000105	0.000775	CcSEcCtD
Glyburide—Diarrhoea—Gemcitabine—kidney cancer	0.000105	0.000775	CcSEcCtD
Glyburide—Jaundice—Doxorubicin—kidney cancer	0.000104	0.000767	CcSEcCtD
Glyburide—Shock—Capecitabine—kidney cancer	0.000104	0.000766	CcSEcCtD
Glyburide—Nervous system disorder—Capecitabine—kidney cancer	0.000103	0.000763	CcSEcCtD
Glyburide—Thrombocytopenia—Capecitabine—kidney cancer	0.000103	0.000762	CcSEcCtD
Glyburide—Vomiting—Vincristine—kidney cancer	0.000103	0.000759	CcSEcCtD
Glyburide—Urticaria—Paclitaxel—kidney cancer	0.000102	0.000753	CcSEcCtD
Glyburide—Rash—Vincristine—kidney cancer	0.000102	0.000753	CcSEcCtD
Glyburide—Hyperhidrosis—Capecitabine—kidney cancer	0.000102	0.000752	CcSEcCtD
Glyburide—Dermatitis—Vincristine—kidney cancer	0.000102	0.000752	CcSEcCtD
Glyburide—Abdominal pain—Paclitaxel—kidney cancer	0.000102	0.00075	CcSEcCtD
Glyburide—Headache—Vincristine—kidney cancer	0.000101	0.000748	CcSEcCtD
Glyburide—Anorexia—Capecitabine—kidney cancer	0.000101	0.000742	CcSEcCtD
Glyburide—Agranulocytosis—Doxorubicin—kidney cancer	9.95e-05	0.000734	CcSEcCtD
Glyburide—Hypotension—Capecitabine—kidney cancer	9.86e-05	0.000727	CcSEcCtD
Glyburide—Vomiting—Gemcitabine—kidney cancer	9.76e-05	0.00072	CcSEcCtD
Glyburide—Rash—Gemcitabine—kidney cancer	9.68e-05	0.000714	CcSEcCtD
Glyburide—Dermatitis—Gemcitabine—kidney cancer	9.67e-05	0.000714	CcSEcCtD
Glyburide—Headache—Gemcitabine—kidney cancer	9.62e-05	0.00071	CcSEcCtD
Glyburide—Nausea—Vincristine—kidney cancer	9.61e-05	0.000709	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Capecitabine—kidney cancer	9.61e-05	0.000709	CcSEcCtD
Glyburide—Hepatitis—Doxorubicin—kidney cancer	9.57e-05	0.000706	CcSEcCtD
Glyburide—Paraesthesia—Capecitabine—kidney cancer	9.47e-05	0.000699	CcSEcCtD
Glyburide—Hypersensitivity—Paclitaxel—kidney cancer	9.47e-05	0.000699	CcSEcCtD
Glyburide—Dyspnoea—Capecitabine—kidney cancer	9.41e-05	0.000694	CcSEcCtD
Glyburide—Dyspepsia—Capecitabine—kidney cancer	9.29e-05	0.000685	CcSEcCtD
Glyburide—Visual impairment—Doxorubicin—kidney cancer	9.22e-05	0.00068	CcSEcCtD
Glyburide—Asthenia—Paclitaxel—kidney cancer	9.22e-05	0.00068	CcSEcCtD
Glyburide—Decreased appetite—Capecitabine—kidney cancer	9.17e-05	0.000677	CcSEcCtD
Glyburide—Nausea—Gemcitabine—kidney cancer	9.12e-05	0.000673	CcSEcCtD
Glyburide—Gastrointestinal disorder—Capecitabine—kidney cancer	9.11e-05	0.000672	CcSEcCtD
Glyburide—Pruritus—Paclitaxel—kidney cancer	9.09e-05	0.000671	CcSEcCtD
Glyburide—Eye disorder—Doxorubicin—kidney cancer	8.94e-05	0.00066	CcSEcCtD
Glyburide—Diarrhoea—Paclitaxel—kidney cancer	8.8e-05	0.000649	CcSEcCtD
Glyburide—Feeling abnormal—Capecitabine—kidney cancer	8.69e-05	0.000641	CcSEcCtD
Glyburide—Gastrointestinal pain—Capecitabine—kidney cancer	8.63e-05	0.000636	CcSEcCtD
Glyburide—Alopecia—Doxorubicin—kidney cancer	8.46e-05	0.000624	CcSEcCtD
Glyburide—Urticaria—Capecitabine—kidney cancer	8.38e-05	0.000618	CcSEcCtD
Glyburide—Abdominal pain—Capecitabine—kidney cancer	8.34e-05	0.000615	CcSEcCtD
Glyburide—Malnutrition—Doxorubicin—kidney cancer	8.33e-05	0.000615	CcSEcCtD
Glyburide—Erythema—Doxorubicin—kidney cancer	8.33e-05	0.000615	CcSEcCtD
Glyburide—Vomiting—Paclitaxel—kidney cancer	8.17e-05	0.000603	CcSEcCtD
Glyburide—Rash—Paclitaxel—kidney cancer	8.11e-05	0.000598	CcSEcCtD
Glyburide—Dermatitis—Paclitaxel—kidney cancer	8.1e-05	0.000597	CcSEcCtD
Glyburide—Headache—Paclitaxel—kidney cancer	8.05e-05	0.000594	CcSEcCtD
Glyburide—Vision blurred—Doxorubicin—kidney cancer	7.85e-05	0.000579	CcSEcCtD
Glyburide—Hypersensitivity—Capecitabine—kidney cancer	7.77e-05	0.000573	CcSEcCtD
Glyburide—Anaemia—Doxorubicin—kidney cancer	7.7e-05	0.000568	CcSEcCtD
Glyburide—Nausea—Paclitaxel—kidney cancer	7.64e-05	0.000563	CcSEcCtD
Glyburide—Asthenia—Capecitabine—kidney cancer	7.57e-05	0.000558	CcSEcCtD
Glyburide—Pruritus—Capecitabine—kidney cancer	7.46e-05	0.000551	CcSEcCtD
Glyburide—Leukopenia—Doxorubicin—kidney cancer	7.46e-05	0.00055	CcSEcCtD
Glyburide—Convulsion—Doxorubicin—kidney cancer	7.22e-05	0.000533	CcSEcCtD
Glyburide—Diarrhoea—Capecitabine—kidney cancer	7.22e-05	0.000532	CcSEcCtD
Glyburide—Arthralgia—Doxorubicin—kidney cancer	7.09e-05	0.000523	CcSEcCtD
Glyburide—Myalgia—Doxorubicin—kidney cancer	7.09e-05	0.000523	CcSEcCtD
Glyburide—Confusional state—Doxorubicin—kidney cancer	6.86e-05	0.000506	CcSEcCtD
Glyburide—Oedema—Doxorubicin—kidney cancer	6.8e-05	0.000502	CcSEcCtD
Glyburide—Vomiting—Capecitabine—kidney cancer	6.71e-05	0.000495	CcSEcCtD
Glyburide—Shock—Doxorubicin—kidney cancer	6.69e-05	0.000494	CcSEcCtD
Glyburide—Nervous system disorder—Doxorubicin—kidney cancer	6.67e-05	0.000492	CcSEcCtD
Glyburide—Thrombocytopenia—Doxorubicin—kidney cancer	6.66e-05	0.000491	CcSEcCtD
Glyburide—Rash—Capecitabine—kidney cancer	6.65e-05	0.000491	CcSEcCtD
Glyburide—Dermatitis—Capecitabine—kidney cancer	6.65e-05	0.00049	CcSEcCtD
Glyburide—Headache—Capecitabine—kidney cancer	6.61e-05	0.000488	CcSEcCtD
Glyburide—Hyperhidrosis—Doxorubicin—kidney cancer	6.57e-05	0.000485	CcSEcCtD
Glyburide—Anorexia—Doxorubicin—kidney cancer	6.48e-05	0.000478	CcSEcCtD
Glyburide—Hypotension—Doxorubicin—kidney cancer	6.35e-05	0.000469	CcSEcCtD
Glyburide—Nausea—Capecitabine—kidney cancer	6.27e-05	0.000462	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.2e-05	0.000457	CcSEcCtD
Glyburide—Paraesthesia—Doxorubicin—kidney cancer	6.11e-05	0.00045	CcSEcCtD
Glyburide—Dyspnoea—Doxorubicin—kidney cancer	6.06e-05	0.000447	CcSEcCtD
Glyburide—Dyspepsia—Doxorubicin—kidney cancer	5.99e-05	0.000442	CcSEcCtD
Glyburide—Decreased appetite—Doxorubicin—kidney cancer	5.91e-05	0.000436	CcSEcCtD
Glyburide—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.87e-05	0.000433	CcSEcCtD
Glyburide—Feeling abnormal—Doxorubicin—kidney cancer	5.6e-05	0.000413	CcSEcCtD
Glyburide—Gastrointestinal pain—Doxorubicin—kidney cancer	5.56e-05	0.00041	CcSEcCtD
Glyburide—Urticaria—Doxorubicin—kidney cancer	5.4e-05	0.000399	CcSEcCtD
Glyburide—Abdominal pain—Doxorubicin—kidney cancer	5.38e-05	0.000397	CcSEcCtD
Glyburide—Hypersensitivity—Doxorubicin—kidney cancer	5.01e-05	0.00037	CcSEcCtD
Glyburide—Asthenia—Doxorubicin—kidney cancer	4.88e-05	0.00036	CcSEcCtD
Glyburide—Pruritus—Doxorubicin—kidney cancer	4.81e-05	0.000355	CcSEcCtD
Glyburide—Diarrhoea—Doxorubicin—kidney cancer	4.65e-05	0.000343	CcSEcCtD
Glyburide—Vomiting—Doxorubicin—kidney cancer	4.32e-05	0.000319	CcSEcCtD
Glyburide—Rash—Doxorubicin—kidney cancer	4.29e-05	0.000316	CcSEcCtD
Glyburide—Dermatitis—Doxorubicin—kidney cancer	4.28e-05	0.000316	CcSEcCtD
Glyburide—Headache—Doxorubicin—kidney cancer	4.26e-05	0.000314	CcSEcCtD
Glyburide—Nausea—Doxorubicin—kidney cancer	4.04e-05	0.000298	CcSEcCtD
Glyburide—ABCC3—Metabolism—ABCB1—kidney cancer	9.87e-06	0.000126	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GPC3—kidney cancer	9.86e-06	0.000126	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—SCARB1—kidney cancer	9.82e-06	0.000126	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—SLC2A1—kidney cancer	9.8e-06	0.000125	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	9.79e-06	0.000125	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ALDH1A1—kidney cancer	9.78e-06	0.000125	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ST3GAL2—kidney cancer	9.77e-06	0.000125	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	9.77e-06	0.000125	CbGpPWpGaD
Glyburide—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	9.76e-06	0.000125	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTGS1—kidney cancer	9.72e-06	0.000124	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	9.69e-06	0.000124	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CA2—kidney cancer	9.59e-06	0.000123	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—GSTM1—kidney cancer	9.58e-06	0.000123	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ALDH1A1—kidney cancer	9.55e-06	0.000122	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PSMD7—kidney cancer	9.53e-06	0.000122	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.51e-06	0.000122	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—CYP1A1—kidney cancer	9.48e-06	0.000121	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—RAF1—kidney cancer	9.45e-06	0.000121	CbGpPWpGaD
Glyburide—ABCC1—Disease—CDKN2B—kidney cancer	9.45e-06	0.000121	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	9.45e-06	0.000121	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SLC5A3—kidney cancer	9.38e-06	0.00012	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PGK1—kidney cancer	9.38e-06	0.00012	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ALAD—kidney cancer	9.35e-06	0.00012	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—RAF1—kidney cancer	9.34e-06	0.00012	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.21e-06	0.000118	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—LDHB—kidney cancer	9.19e-06	0.000118	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PGK1—kidney cancer	9.15e-06	0.000117	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SLC5A3—kidney cancer	9.15e-06	0.000117	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PDHB—kidney cancer	9.13e-06	0.000117	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ST3GAL2—kidney cancer	9.12e-06	0.000117	CbGpPWpGaD
Glyburide—CYP3A4—Biological oxidations—POMC—kidney cancer	9.1e-06	0.000116	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—CYP1A1—kidney cancer	9.09e-06	0.000116	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—GSTP1—kidney cancer	9.08e-06	0.000116	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—BCHE—kidney cancer	9.04e-06	0.000116	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—LDHB—kidney cancer	8.97e-06	0.000115	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	8.97e-06	0.000115	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—POMC—kidney cancer	8.94e-06	0.000114	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—SLC5A5—kidney cancer	8.93e-06	0.000114	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ALDH1A1—kidney cancer	8.92e-06	0.000114	CbGpPWpGaD
Glyburide—ALB—Metabolism—CA9—kidney cancer	8.88e-06	0.000114	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.68e-06	0.000111	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—POMC—kidney cancer	8.67e-06	0.000111	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	8.66e-06	0.000111	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—SLC2A1—kidney cancer	8.62e-06	0.00011	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—ABCB1—kidney cancer	8.6e-06	0.00011	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CCBL1—kidney cancer	8.58e-06	0.00011	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PGK1—kidney cancer	8.55e-06	0.000109	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SLC5A3—kidney cancer	8.55e-06	0.000109	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	8.53e-06	0.000109	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—LDHB—kidney cancer	8.38e-06	0.000107	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—GSTM1—kidney cancer	8.35e-06	0.000107	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.29e-06	0.000106	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	8.22e-06	0.000105	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	8.2e-06	0.000105	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—GSTP1—kidney cancer	8.17e-06	0.000105	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	8.07e-06	0.000103	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CA9—kidney cancer	7.97e-06	0.000102	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—CYP1A1—kidney cancer	7.91e-06	0.000101	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	7.85e-06	0.0001	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	7.8e-06	9.98e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.79e-06	9.97e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.79e-06	9.96e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CA9—kidney cancer	7.78e-06	9.95e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ABCB1—kidney cancer	7.74e-06	9.9e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	7.68e-06	9.82e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—HIF1A—kidney cancer	7.56e-06	9.67e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CRABP1—kidney cancer	7.55e-06	9.66e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—TSC2—kidney cancer	7.54e-06	9.65e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—GSTM1—kidney cancer	7.51e-06	9.61e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.46e-06	9.55e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PPAT—kidney cancer	7.44e-06	9.52e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GLIPR1—kidney cancer	7.44e-06	9.52e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CA9—kidney cancer	7.27e-06	9.3e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	7.25e-06	9.28e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—GSTP1—kidney cancer	7.19e-06	9.2e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PTGS2—kidney cancer	7.13e-06	9.12e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CYP1A1—kidney cancer	7.12e-06	9.11e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.1e-06	9.09e-05	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—PIK3CA—kidney cancer	7.1e-06	9.08e-05	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—PIK3CA—kidney cancer	7.1e-06	9.08e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—POMC—kidney cancer	7.07e-06	9.04e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—ITPR2—kidney cancer	7.02e-06	8.98e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—APRT—kidney cancer	6.92e-06	8.85e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—FH—kidney cancer	6.92e-06	8.85e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PTGS2—kidney cancer	6.91e-06	8.84e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ABCB1—kidney cancer	6.81e-06	8.71e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CRABP1—kidney cancer	6.78e-06	8.67e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—POMC—kidney cancer	6.77e-06	8.67e-05	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	6.77e-06	8.66e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	6.66e-06	8.52e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—KIT—kidney cancer	6.66e-06	8.52e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—APC—kidney cancer	6.66e-06	8.52e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CRABP1—kidney cancer	6.62e-06	8.46e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—GSTM1—kidney cancer	6.61e-06	8.45e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GPC3—kidney cancer	6.5e-06	8.32e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.5e-06	8.32e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.47e-06	8.28e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	6.45e-06	8.25e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTT1—kidney cancer	6.4e-06	8.19e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—ACHE—kidney cancer	6.4e-06	8.19e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CA2—kidney cancer	6.33e-06	8.09e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ITPR2—kidney cancer	6.3e-06	8.06e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CYP1A1—kidney cancer	6.26e-06	8.01e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—BRAF—kidney cancer	6.26e-06	8.01e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PTEN—kidney cancer	6.22e-06	7.95e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CRABP1—kidney cancer	6.18e-06	7.91e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALAD—kidney cancer	6.16e-06	7.89e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ITPR2—kidney cancer	6.15e-06	7.87e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—SCARB1—kidney cancer	6.06e-06	7.75e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PTEN—kidney cancer	6.03e-06	7.71e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ST3GAL2—kidney cancer	6.02e-06	7.7e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTGS1—kidney cancer	6e-06	7.67e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—POMC—kidney cancer	5.9e-06	7.55e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PSMD7—kidney cancer	5.88e-06	7.53e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALDH1A1—kidney cancer	5.88e-06	7.52e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—RAF1—kidney cancer	5.86e-06	7.5e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.85e-06	7.48e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.81e-06	7.43e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ACHE—kidney cancer	5.75e-06	7.35e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTT1—kidney cancer	5.75e-06	7.35e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ITPR2—kidney cancer	5.75e-06	7.35e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC5A3—kidney cancer	5.64e-06	7.21e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PGK1—kidney cancer	5.64e-06	7.21e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PTGS2—kidney cancer	5.64e-06	7.21e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ACHE—kidney cancer	5.61e-06	7.18e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTT1—kidney cancer	5.61e-06	7.18e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—BCHE—kidney cancer	5.58e-06	7.13e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—LDHB—kidney cancer	5.53e-06	7.07e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—SLC5A5—kidney cancer	5.51e-06	7.05e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SCARB1—kidney cancer	5.44e-06	6.96e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTGS2—kidney cancer	5.4e-06	6.91e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTGS1—kidney cancer	5.39e-06	6.89e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—SLC2A1—kidney cancer	5.32e-06	6.81e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SCARB1—kidney cancer	5.31e-06	6.79e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—POMC—kidney cancer	5.31e-06	6.79e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.3e-06	6.78e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PSMD7—kidney cancer	5.28e-06	6.76e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTGS1—kidney cancer	5.26e-06	6.72e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—IL2—kidney cancer	5.26e-06	6.72e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTT1—kidney cancer	5.24e-06	6.7e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ACHE—kidney cancer	5.24e-06	6.7e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—RAF1—kidney cancer	5.23e-06	6.69e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—ERBB2—kidney cancer	5.17e-06	6.61e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.16e-06	6.6e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PSMD7—kidney cancer	5.15e-06	6.59e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MTOR—kidney cancer	5.1e-06	6.53e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CD4—kidney cancer	5.09e-06	6.52e-05	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	5.07e-06	6.49e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTGS2—kidney cancer	5.06e-06	6.47e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—BCHE—kidney cancer	5.01e-06	6.4e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SCARB1—kidney cancer	4.96e-06	6.35e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SLC5A5—kidney cancer	4.95e-06	6.33e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PTEN—kidney cancer	4.92e-06	6.29e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTGS1—kidney cancer	4.91e-06	6.28e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—BCHE—kidney cancer	4.89e-06	6.25e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SLC5A5—kidney cancer	4.83e-06	6.17e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PSMD7—kidney cancer	4.82e-06	6.16e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CA9—kidney cancer	4.79e-06	6.13e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CDKN1B—kidney cancer	4.79e-06	6.13e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SLC2A1—kidney cancer	4.78e-06	6.11e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTEN—kidney cancer	4.71e-06	6.03e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTGS2—kidney cancer	4.71e-06	6.02e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—POMC—kidney cancer	4.67e-06	5.98e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SLC2A1—kidney cancer	4.66e-06	5.96e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.63e-06	5.93e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—BCHE—kidney cancer	4.56e-06	5.84e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CTNNB1—kidney cancer	4.52e-06	5.79e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SLC5A5—kidney cancer	4.51e-06	5.77e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.5e-06	5.76e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—VEGFA—kidney cancer	4.47e-06	5.71e-05	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.45e-06	5.69e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTP1—kidney cancer	4.44e-06	5.68e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTEN—kidney cancer	4.41e-06	5.64e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PIK3CA—kidney cancer	4.39e-06	5.61e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SLC2A1—kidney cancer	4.35e-06	5.57e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CA—kidney cancer	4.25e-06	5.44e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTGS2—kidney cancer	4.23e-06	5.42e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.23e-06	5.41e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—MAPK3—kidney cancer	4.22e-06	5.41e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—ABCB1—kidney cancer	4.2e-06	5.37e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTEN—kidney cancer	4.1e-06	5.25e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTM1—kidney cancer	4.08e-06	5.22e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CRABP1—kidney cancer	4.08e-06	5.21e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.04e-06	5.17e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—MAPK1—kidney cancer	4.02e-06	5.14e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTP1—kidney cancer	3.98e-06	5.1e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTP1—kidney cancer	3.89e-06	4.97e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP1A1—kidney cancer	3.87e-06	4.95e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—KRAS—kidney cancer	3.8e-06	4.86e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ITPR2—kidney cancer	3.79e-06	4.85e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ABCB1—kidney cancer	3.77e-06	4.82e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MAPK3—kidney cancer	3.77e-06	4.82e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTGS2—kidney cancer	3.73e-06	4.77e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTEN—kidney cancer	3.69e-06	4.72e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.68e-06	4.71e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MYC—kidney cancer	3.66e-06	4.69e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTM1—kidney cancer	3.66e-06	4.68e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTP1—kidney cancer	3.63e-06	4.65e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MAPK1—kidney cancer	3.58e-06	4.59e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTM1—kidney cancer	3.57e-06	4.57e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CA—kidney cancer	3.49e-06	4.46e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP1A1—kidney cancer	3.47e-06	4.44e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CA—kidney cancer	3.47e-06	4.44e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTT1—kidney cancer	3.46e-06	4.42e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ACHE—kidney cancer	3.46e-06	4.42e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ABCB1—kidney cancer	3.44e-06	4.4e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP1A1—kidney cancer	3.39e-06	4.33e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—KRAS—kidney cancer	3.39e-06	4.33e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TP53—kidney cancer	3.37e-06	4.32e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTM1—kidney cancer	3.34e-06	4.27e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CA—kidney cancer	3.32e-06	4.25e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SCARB1—kidney cancer	3.27e-06	4.19e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTEN—kidney cancer	3.25e-06	4.16e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTGS1—kidney cancer	3.24e-06	4.14e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.18e-06	4.06e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PSMD7—kidney cancer	3.18e-06	4.06e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP1A1—kidney cancer	3.16e-06	4.05e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CA—kidney cancer	3.11e-06	3.98e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—BCHE—kidney cancer	3.01e-06	3.85e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.97e-06	3.8e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CA—kidney cancer	2.89e-06	3.7e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—POMC—kidney cancer	2.88e-06	3.69e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.87e-06	3.67e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.85e-06	3.65e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CA—kidney cancer	2.6e-06	3.33e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.6e-06	3.33e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—POMC—kidney cancer	2.59e-06	3.31e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—POMC—kidney cancer	2.53e-06	3.23e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTP1—kidney cancer	2.4e-06	3.06e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—POMC—kidney cancer	2.36e-06	3.02e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTGS2—kidney cancer	2.3e-06	2.94e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CA—kidney cancer	2.29e-06	2.93e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ABCB1—kidney cancer	2.27e-06	2.9e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTM1—kidney cancer	2.2e-06	2.82e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.09e-06	2.67e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTGS2—kidney cancer	2.06e-06	2.64e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTGS2—kidney cancer	2.01e-06	2.58e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTEN—kidney cancer	2e-06	2.56e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTGS2—kidney cancer	1.88e-06	2.41e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTEN—kidney cancer	1.8e-06	2.3e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTEN—kidney cancer	1.76e-06	2.25e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTEN—kidney cancer	1.64e-06	2.1e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—POMC—kidney cancer	1.56e-06	1.99e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CA—kidney cancer	1.41e-06	1.81e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.27e-06	1.62e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTGS2—kidney cancer	1.24e-06	1.59e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CA—kidney cancer	1.24e-06	1.59e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.16e-06	1.48e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTEN—kidney cancer	1.08e-06	1.38e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CA—kidney cancer	7.63e-07	9.77e-06	CbGpPWpGaD
